
John D. Ulm
Examiner (ID: 10769, Phone: (571)272-0880 , Office: P/1649 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1649, 1812, 1646, 1805 |
| Total Applications | 2240 |
| Issued Applications | 1195 |
| Pending Applications | 205 |
| Abandoned Applications | 843 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5204968
[patent_doc_number] => 20070026449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'NOVEL HUMAN SODIUM-DEPENDENT PHOSPHATE COTRANSPORTER'
[patent_app_type] => utility
[patent_app_number] => 11/534950
[patent_app_country] => US
[patent_app_date] => 2006-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17187
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20070026449.pdf
[firstpage_image] =>[orig_patent_app_number] => 11534950
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/534950 | NOVEL HUMAN SODIUM-DEPENDENT PHOSPHATE COTRANSPORTER | Sep 24, 2006 | Abandoned |
Array
(
[id] => 5010827
[patent_doc_number] => 20070281306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/524793
[patent_app_country] => US
[patent_app_date] => 2006-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 227233
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20070281306.pdf
[firstpage_image] =>[orig_patent_app_number] => 11524793
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/524793 | Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor | Sep 20, 2006 | Abandoned |
Array
(
[id] => 5106564
[patent_doc_number] => 20070065441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Human PF4A receptors, nucleic acid encoding and antibodies binding thereto'
[patent_app_type] => utility
[patent_app_number] => 11/524232
[patent_app_country] => US
[patent_app_date] => 2006-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 23755
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20070065441.pdf
[firstpage_image] =>[orig_patent_app_number] => 11524232
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/524232 | Human PF4A receptors, nucleic acid encoding and antibodies binding thereto | Sep 18, 2006 | Abandoned |
Array
(
[id] => 5075226
[patent_doc_number] => 20070015201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/522789
[patent_app_country] => US
[patent_app_date] => 2006-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80352
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20070015201.pdf
[firstpage_image] =>[orig_patent_app_number] => 11522789
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/522789 | Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor | Sep 17, 2006 | Abandoned |
Array
(
[id] => 341368
[patent_doc_number] => 07501123
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-10
[patent_title] => 'Human G-protein chemokine receptor (CCR5) HDGNR10'
[patent_app_type] => utility
[patent_app_number] => 11/518949
[patent_app_country] => US
[patent_app_date] => 2006-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 187784
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/501/07501123.pdf
[firstpage_image] =>[orig_patent_app_number] => 11518949
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/518949 | Human G-protein chemokine receptor (CCR5) HDGNR10 | Sep 11, 2006 | Issued |
Array
(
[id] => 5367841
[patent_doc_number] => 20090305400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Modified chaperonin 10'
[patent_app_type] => utility
[patent_app_number] => 11/991279
[patent_app_country] => US
[patent_app_date] => 2006-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 23183
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20090305400.pdf
[firstpage_image] =>[orig_patent_app_number] => 11991279
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/991279 | Modified chaperonin 10 | Aug 30, 2006 | Issued |
Array
(
[id] => 4988608
[patent_doc_number] => 20070154947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Chemical biodiscriminator'
[patent_app_type] => utility
[patent_app_number] => 11/513594
[patent_app_country] => US
[patent_app_date] => 2006-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14865
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20070154947.pdf
[firstpage_image] =>[orig_patent_app_number] => 11513594
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/513594 | Chemical biodiscriminator | Aug 30, 2006 | Abandoned |
Array
(
[id] => 7555260
[patent_doc_number] => 08067161
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-29
[patent_title] => 'Dopaminergic neuron proliferative progenitor cell marker Nato3'
[patent_app_type] => utility
[patent_app_number] => 12/064018
[patent_app_country] => US
[patent_app_date] => 2006-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 14107
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/067/08067161.pdf
[firstpage_image] =>[orig_patent_app_number] => 12064018
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/064018 | Dopaminergic neuron proliferative progenitor cell marker Nato3 | Aug 17, 2006 | Issued |
Array
(
[id] => 5604267
[patent_doc_number] => 20060294614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Murine genomic polynucleotide sequence encoding a G-protein coupled receptor and methods of use therefor'
[patent_app_type] => utility
[patent_app_number] => 11/504059
[patent_app_country] => US
[patent_app_date] => 2006-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 41499
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0294/20060294614.pdf
[firstpage_image] =>[orig_patent_app_number] => 11504059
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/504059 | Murine genomic polynucleotide sequence encoding a G-protein coupled receptor and methods of use therefor | Aug 13, 2006 | Abandoned |
Array
(
[id] => 5290009
[patent_doc_number] => 20090022739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'MODULATING THE KV1.1 VOLTAGE-GATED POTASSIUM CHANNEL IN T-CELLS FOR REGULATING THE SYNTHESIS AND SECRETION OF TUMOR NECROSIS FACTOR ALPHA (tnf-ALPHA) AND TREATING HUMAN DISEASE OR INJURIES MEDIATED BY DETRIMENTALLY HIGH OR LOW LEVELS OF TNF-ALPHA'
[patent_app_type] => utility
[patent_app_number] => 11/997776
[patent_app_country] => US
[patent_app_date] => 2006-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15730
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20090022739.pdf
[firstpage_image] =>[orig_patent_app_number] => 11997776
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/997776 | MODULATING THE KV1.1 VOLTAGE-GATED POTASSIUM CHANNEL IN T-CELLS FOR REGULATING THE SYNTHESIS AND SECRETION OF TUMOR NECROSIS FACTOR ALPHA (tnf-ALPHA) AND TREATING HUMAN DISEASE OR INJURIES MEDIATED BY DETRIMENTALLY HIGH OR LOW LEVELS OF TNF-ALPHA | Aug 2, 2006 | Abandoned |
Array
(
[id] => 4982830
[patent_doc_number] => 20070087388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-19
[patent_title] => 'G protein coupled receptor'
[patent_app_type] => utility
[patent_app_number] => 11/494775
[patent_app_country] => US
[patent_app_date] => 2006-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15570
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20070087388.pdf
[firstpage_image] =>[orig_patent_app_number] => 11494775
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/494775 | G protein coupled receptor | Jul 27, 2006 | Abandoned |
Array
(
[id] => 5177423
[patent_doc_number] => 20070178483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'Novel cell-based assays for G-protein-coupled receptor-mediated activities'
[patent_app_type] => utility
[patent_app_number] => 11/492216
[patent_app_country] => US
[patent_app_date] => 2006-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 15735
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20070178483.pdf
[firstpage_image] =>[orig_patent_app_number] => 11492216
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/492216 | Cell-based assay for G-protein-coupled receptor-mediated activity employing a mutated cyclic nucleotide-gated ion channel and a membrane potential dye | Jul 24, 2006 | Issued |
Array
(
[id] => 6573458
[patent_doc_number] => 20100129288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'Gliomedin, Fragments Thereof and Methods of Using Same'
[patent_app_type] => utility
[patent_app_number] => 11/993711
[patent_app_country] => US
[patent_app_date] => 2006-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 16520
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20100129288.pdf
[firstpage_image] =>[orig_patent_app_number] => 11993711
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/993711 | Gliomedin, Fragments Thereof and Methods of Using Same | Jun 27, 2006 | Abandoned |
Array
(
[id] => 6430514
[patent_doc_number] => 20100143322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'USE OF INHIBITORS OF N-METHYL TRANSFERASES FOR THE THERAPY OF PARKINSON\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 11/993738
[patent_app_country] => US
[patent_app_date] => 2006-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2747
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143322.pdf
[firstpage_image] =>[orig_patent_app_number] => 11993738
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/993738 | USE OF INHIBITORS OF N-METHYL TRANSFERASES FOR THE THERAPY OF PARKINSON'S DISEASE | Jun 25, 2006 | Abandoned |
Array
(
[id] => 5075245
[patent_doc_number] => 20070015220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Novel guanosine triphosphate (GTP) binding protein-coupled receptor proteins'
[patent_app_type] => utility
[patent_app_number] => 11/447407
[patent_app_country] => US
[patent_app_date] => 2006-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12444
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20070015220.pdf
[firstpage_image] =>[orig_patent_app_number] => 11447407
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/447407 | Guanosine triphosphate (GTP) binding protein-coupled receptor proteins that bind histamine and are expressed in the brain | Jun 5, 2006 | Issued |
Array
(
[id] => 5051351
[patent_doc_number] => 20070031896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Anti-CCR4 antibodies and methods of use therefor'
[patent_app_type] => utility
[patent_app_number] => 11/447689
[patent_app_country] => US
[patent_app_date] => 2006-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 17102
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031896.pdf
[firstpage_image] =>[orig_patent_app_number] => 11447689
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/447689 | Anti-CCR4 antibodies and methods of use therefor | Jun 4, 2006 | Abandoned |
Array
(
[id] => 5171832
[patent_doc_number] => 20070072264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'RECOMBINANT CHIMERIC ACETYLCHOLINE RECEPTORS AND THEIR DERIVATIVES RECOGNIZED BY CD4 T CELLS OF MYASTHENIC PATIENTS FOR THE TREATMENT OF MYASTHENIA GRAVIS'
[patent_app_type] => utility
[patent_app_number] => 11/421433
[patent_app_country] => US
[patent_app_date] => 2006-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7392
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20070072264.pdf
[firstpage_image] =>[orig_patent_app_number] => 11421433
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/421433 | Recombinant chimeric acetylcholine receptors and their derivatives recognized by CD4 T cells of myasthenic patients for the treatment of myasthenia gravis | May 30, 2006 | Issued |
Array
(
[id] => 5851114
[patent_doc_number] => 20060234305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Gene encoding G-protein coupled receptor and gene product thereof'
[patent_app_type] => utility
[patent_app_number] => 11/436904
[patent_app_country] => US
[patent_app_date] => 2006-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 42317
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234305.pdf
[firstpage_image] =>[orig_patent_app_number] => 11436904
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/436904 | Assay employing a g-protein coupled receptor that is activated by CCK-8S | May 17, 2006 | Issued |
Array
(
[id] => 5732794
[patent_doc_number] => 20060257911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'G-protein coupled receptors'
[patent_app_type] => utility
[patent_app_number] => 11/429430
[patent_app_country] => US
[patent_app_date] => 2006-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 42582
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257911.pdf
[firstpage_image] =>[orig_patent_app_number] => 11429430
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/429430 | Isolated polynucleotide encoding a G-protein coupled receptor | May 7, 2006 | Issued |
Array
(
[id] => 5688295
[patent_doc_number] => 20060286610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Identification of ligands by selective amplification of cells transfected with receptors'
[patent_app_type] => utility
[patent_app_number] => 11/417083
[patent_app_country] => US
[patent_app_date] => 2006-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 24660
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20060286610.pdf
[firstpage_image] =>[orig_patent_app_number] => 11417083
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/417083 | Identification of ligands by selective amplification of cells transfected with receptors | May 2, 2006 | Issued |